137 related articles for article (PubMed ID: 32804778)
1. Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.
Goksu SY; Ozer M; Kazmi SMA; Aguilera TA; Ahn C; Hsiehchen D; Sanjeevaiah A; Maxwell MC; Beg MS; Sanford NN
Am J Clin Oncol; 2020 Nov; 43(11):762-769. PubMed ID: 32804778
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.
Bian SX; Chen DH; Lin E
Cancer Med; 2021 Jan; 10(2):575-585. PubMed ID: 33305908
[TBL] [Abstract][Full Text] [Related]
3. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic disparities in timeliness of care and outcomes for anal cancer patients.
Ahmad TR; Susko M; Lindquist K; Anwar M
Cancer Med; 2019 Dec; 8(17):7186-7196. PubMed ID: 31595720
[TBL] [Abstract][Full Text] [Related]
5. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.
Patel KS; Alhatem A; Gadde U; Ahlawat S; Lambert C; Schwartz RA; Dalla Piazza M
Cancer Epidemiol; 2020 Aug; 67():101723. PubMed ID: 32408241
[TBL] [Abstract][Full Text] [Related]
6. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.
Goffredo P; Utria AF; Hrabe JE; Gribovskaja-Rupp I; Kapadia MR; Hassan I
J Gastrointest Surg; 2019 Apr; 23(4):712-719. PubMed ID: 30644029
[TBL] [Abstract][Full Text] [Related]
7. Does race impact survival for patients with anal squamous cell carcinoma?
Fields AC; Welten VM; Lu P; Goldberg JE; Irani J; Bleday R; Melnitchouk N
J Surg Oncol; 2019 Dec; 120(7):1201-1207. PubMed ID: 31549446
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
10. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
12. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
13. Race- and Sex-Based Disparities in the Therapy and Outcomes of Squamous Cell Carcinoma of the Anus.
Arora N; Gupta A; Zhu H; Christie A; Meyer JJ; Khan SA; Beg MS
J Natl Compr Canc Netw; 2017 Aug; 15(8):998-1004. PubMed ID: 28784861
[No Abstract] [Full Text] [Related]
14. Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
Abdelazim YA; Rushing CN; Palta M; Willett CG; Czito BG
Cancer; 2019 Jun; 125(12):2115-2122. PubMed ID: 30825391
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
Elson JK; Kachnic LA; Kharofa JR
Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in tumor features and outcomes of patients with squamous cell carcinoma of the tonsil.
Albert A; Giri S; Kanakamedala M; Mangana S; Bhanat E; Shenoy V; Thomas TV; Joseph S; Gonzalez M; Shalaby A; Vijayakumar S
Laryngoscope; 2019 Mar; 129(3):643-654. PubMed ID: 30152118
[TBL] [Abstract][Full Text] [Related]
17. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
18. Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer.
Goodman KA; Julie D; Cercek A; Cambridge L; Woo KM; Zhang Z; Wu AJ; Reidy DL; Segal NH; Stadler ZK; Saltz LB
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1087-1095. PubMed ID: 28721892
[TBL] [Abstract][Full Text] [Related]
19. Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma.
Abdel-Rahman O; Ghosh S
Am J Clin Oncol; 2023 Jan; 46(1):31-35. PubMed ID: 36453694
[TBL] [Abstract][Full Text] [Related]
20. Management of anal intraepithelial neoplasia and anal squamous cell carcinoma at a tertiary referral centre with a dedicated infectious diseases unit: an 18-year review.
Power Foley M; Kelly ME; Kerr C; Kennedy C; Gallagher D; Gillham C; Mehigan BJ; McCormick PH; Bergin C; Larkin JO
Int J Colorectal Dis; 2020 Oct; 35(10):1855-1864. PubMed ID: 32500433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]